LncRNA Gm15834通过与Sam68相互作用并激活NF-κB介导炎症而加剧心脏缩
Yongsheng Liu1, Man Jiang1, Meitian Zhang1
1Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang, 163319, China.
Cardiovascular drugs and therapy
|May 8, 2024
概括
这项研究确定了一种新的长非编码RNA (lncRNA) 途径,涉及Gm15834和Sam68,通过通过NF-κB信号控制炎症来调节心脏缩.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 心脏缩是心血管疾病中常见的病理,其分子机制不明确.
- 长非编码RNAs (lncRNAs) 正在成为心血管疾病发展的关键调节者.
- 这项研究揭示了心脏缩中一种新的IncRNA调节途径.
研究的目的:
- 阐明 lncRNA Gm15834 在心脏缩中的作用.
- 为了研究lncRNA Gm15834,Sam68和NF-κB信号传递之间的分子相互作用.
- 为了确定心脏缩的潜在治疗点.
主要方法:
- 用小鼠的横向大动脉收缩 (TAC) 和HL-1心肌细胞中的血管素II (AngII) 来建立心脏缩模型.
- 腺相关病毒9 (AAV9) 用于体内操纵,而等离子体则在体内促进了lncRNA Gm15834的过度表达和淘汰.
- 技术包括HE染色,免疫光,回声心脏学,西部斑点和RNA免疫沉 (RIP) 来评估组织结构,心脏功能,蛋白质表达和分子结合.
主要成果:
- 在心脏缩模型中,抑制lncRNA Gm15834降低了Sam68表达和NF-κB介导的炎症活性.
- 过度表达lncRNA Gm15834产生了相反的效果,加剧了缩.
- RNA免疫沉证实了lncRNA Gm15834和Sam68之间的直接结合,而Sam68的过度表达抵消了lncRNA Gm15834敲击的抗增高作用.
结论:
- 在心脏缩中发现了一种新的调节轴, lncRNA Gm15834/Sam68/NF-κB/炎症.
- 这一途径为心脏缩的分子机制提供了新的见解.
- 这些发现突出了lncRNA Gm15834作为在心脏缩中临床干预的潜在治疗点.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:04Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
01:31Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K